24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
66.67% |
|
ENZYME DYNAMICS |
19.84% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
8.73% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
4.76% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
45.23% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
29.74% |
|
ENZYME DYNAMICS |
13.58% |
|
NIPAH VIRUS DECOY PROTEIN DESIGN |
10.66% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
.79% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
49.91% |
|
CANCER |
26.82% |
|
INFLUENZA |
7.52% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
6.55% |
|
ANTIBODY DYNAMICS SIMULATION |
5.27% |
|
NIPAH VIRUS DECOY PROTEIN DESIGN |
1.51% |
|
ANTIBODY AFFINITY MATURATION |
.83% |
|
NIPAH VIRUS DECOY PROTEIN SIMULATION |
.8% |
|
SUCROSE TRANSPORTER ATSUC1 |
.35% |
|
IL 2 FORCE FIELD BENCHMARKING |
.3% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
.11% |
|
ALZHEIMERS |
.02% |